TrueShares标普自动赎回防御型收益主动型ETF PAYM 深 沪
等待开盘 03-26 09:30:00 美东时间
23.44
+0.100
+0.43%
华盛通- 最 高23.46
- 今 开23.315
- 成交量 5005股
- 最 低 23.1901
- 昨 收 23.34
- 总市值 6422.56万
- 52周最高 26.0344
- 市盈率 静 --
- 换手率 0.18%
- 52周最低 22.81
- 委 比 0.00%
- 总股本 274.00万
- 历史最高 26.0344
- 量 比 0.08
- 振 幅 1.16%
- 历史最低 22.81
- 每 手 1
- 风险率 0.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Alteogen Enters Into A License Agreement With Biogen For Development And Commercialization Of Hybrozyme™-Based Subcutaneous Biologics
BRIEF-Alteogen Enters Into A License Agreement With Biogen For Development And Commercialization Of Hybrozyme™-Based Subcutaneous Biologics Alteogen Inc 196170.KQ : ALTEOGEN ENTERS INTO A LICENSE AGREEMENT WITH BIOGEN FOR DEVELOPMENT AND COMMERCIALIZATION OF HYBROZYME™-BASED SUBCUTANEOUS BIOLOGICS A
03-25 20:30
RPT-Iranian oil is offered to India at premium to Brent, sources say
RPT-Iranian oil is offered to India at premium to Brent, sources say Repeats story published on March 23 with no changes to text Indian refiners are keen to buy Iranian oil and LPG to meet supply gap Traders seek payments in dollars or rupees India has not bought Iranian crude since 2019 By Nidhi Ve
03-24 10:47
BRIEF-Empery Digital Announces $25 Million Registered Direct Offering
BRIEF-Empery Digital Announces $25 Million Registered Direct Offering Empery Digital Inc EMPD.O : EMPERY DIGITAL ANNOUNCES $25 MILLION REGISTERED DIRECT OFFERING EMPERY DIGITAL INC - NET PROCEEDS TO REDUCE DEBT BY $40 MILLION INCLUDING FULL REPAYMENT OF $50 MILLION REPO FACILITY Source text: ID:nBwb
03-23 20:49
UPDATE 1-UK Stocks-Factors to watch on March 20
UPDATE 1-UK Stocks-Factors to watch on March 20 Adds news items March 20 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday, with futures FFIc1 up 0.46%. * UNILEVER: Unilever ULVR.L said it was in talks with McCormick & Company MKC.N about selling its foods business. * CAB P
03-20 15:59
BRIEF-Embecta Announces Definitive Agreement To Acquire Owen Mumford Holdings Limited
BRIEF-Embecta Announces Definitive Agreement To Acquire Owen Mumford Holdings Limited March 19 (Reuters) - Embecta Corp EMBC.O : EMBECTA ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE OWEN MUMFORD HOLDINGS LIMITED EMBECTA CORP - DEAL INCLUDES £100 MILLION UPFRONT AND UP TO £50 MILLION PERFORMANCE-BASED P
03-19 19:52
Monte Rosa Therapeutics Q4 revenue drops, net loss widens on lower milestone payments
Monte Rosa Therapeutics Q4 revenue drops, net loss widens on lower milestone payments Overview Biotechnology firm's Q4 collaboration revenue fell sharply yr/yr amid lower milestone payments Q4 net loss widened as R&D expenses rose on MRT-8102 and other programs Company completed $345 mln equity offe
03-17 19:08
Seres Therapeutics posts 2025 profit as expenses fall
Seres Therapeutics posts 2025 profit as expenses fall Overview US biotechnology firm's 2025 net income from continuing ops was $5.7 mln, reversing prior loss 2025 revenue was $789,000 as company focused on early-stage pipeline and transition services Seres cut R&D and G&A expenses yr/yr as it priori
03-12 19:14
BRIEF-Kosmos Energy Announces Launch Of $175 Million Public Offering Of Common Stock
BRIEF-Kosmos Energy Announces Launch Of $175 Million Public Offering Of Common Stock March 11 (Reuters) - Kosmos Energy Ltd KOS.N : KOSMOS ENERGY LTD - LAUNCHES $175 MILLION PUBLIC OFFERING OF COMMON STOCK KOSMOS ENERGY LTD - UNDERWRITERS GRANTED 30-DAY OPTION TO PURCHASE UP TO $26.25 MILLION ADDITI
03-11 15:33
BRIEF-Parex Resources Enters Into A Definitive Agreement To Acquire Frontera Energy's Colombian E&P Assets
BRIEF-Parex Resources Enters Into A Definitive Agreement To Acquire Frontera Energy's Colombian E&P Assets March 10 (Reuters) - Parex Resources Inc PXT.TO : PAREX RESOURCES ENTERS INTO A DEFINITIVE AGREEMENT TO ACQUIRE FRONTERA ENERGY’S COLOMBIAN E&P ASSETS PAREX RESOURCES INC - TO BUY 100% OF FRONT
03-11 08:03
BRIEF-EU Approves Four‑week Dosing Option For Chiesi and Protalix’s Elfabrio
BRIEF-EU Approves Four‑week Dosing Option For Chiesi and Protalix’s Elfabrio March 9 (Reuters) - Protalix Biotherapeutics Inc PBDA.F : CHIESI GLOBAL RARE DISEASES AND PROTALIX BIOTHERAPEUTICS ANNOUNCE EUROPEAN COMMISSION APPROVAL OF ADDITIONAL DOSING REGIMEN OF EVERY FOUR WEEKS FOR ELFABRIO® (PEGUNI
03-09 19:04
